Making dressing
less distressing
What is Epidermolysis Bullosa (EB)?
Epidermolysis Bullosa (EB) is a rare, inherited group of skin disorders characterised by extreme skin fragility. The merest touch – a bump or even a hug – can cause painful wounds and severe blistering. A life overshadowed by pain, distress, endless dressing changes and treatments.
EB can vary in severity in symptoms, ranging from mild to severe. However, pain and discomfort is experienced by all patients. The suffering isn’t just limited to the skin, but extends to the psychological, the dread of a dressing change, a life dictated by routine and regime. The impact on patients, families, caregivers and healthcare professionals can be devastating.
Dedicated to improving lives of the EB community
At Mölnlycke®, we are committed to improving the experience for all those living with or alongside EB. That’s why we created Safetac®, the original soft silicone adhesion designed with one key reason, to minimise pain and suffering during dressing changes 2 3 4 5 6 7 8 9 10 .
Skin friendly solutions with Safetac
Our dressings with Safetac® hug the wound without sticking to it, protecting the skin around it 9 . They conform softly, minimising damage to the skin at dressing removal and promoting faster healing 2 - 5 10 .
So much more than a technology, Safetac is a feeling. It sets a new standard for what life could look like for the EB community.
Mölnlycke® first invented Safetac over 30 years ago and we continue to develop skin friendly solutions, committed into the future to reducing pain and suffering 2 - 7 10 .
Education and clinical resources
Although we cannot cure EB, we are here to support. Visit our Mölnlycke Advantage hub to advance your knowledge on EB with clinical resources and flexible, on-demand training including:
- Educational webinars
- Additional information and educational resources
Download the clinical resources
Setting better standards of care, now and into the future
Our commitment to EB doesn’t stop here. Mölnlycke are a proud sponsor of patient associations and EB communities across the world. We have invested in research and development and will continue to challenge ourselves into the future. We are dedicated to keep setting the standard of care and making dressing less distressing for all those living with or alongside EB.
'References'
- DEBRA (www.debra.org.uk/what-is-eb). Accessed 20/10/2017.
- Beele H. et al. A prospective randomized controlled clinical investigation comparing two post-operative wound dressings used after elective hip and knee replacement; Mepilex® Border Post-Op versus Aquacel® Surgical. International Journal of Orthopaedic and Trauma Nursing, 2020
- Silverstein P, et al. An open, parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream. J Burn Care Res. 2011;32(6):617-626.
- Gee Kee EL, et al. Randomized controlled trial of three burns dressings for partial thickness burns in children. Burns. 2015;41(5):946-955.
- David F. et al. A randomised, controlled, non-inferiority trial comparing the performance of a soft silicone-coated wound contact layer (Mepitel One) with a lipidocolloid wound contact layer (UrgoTul) in the treatment of acute wounds. International Wound Journal, 2018.
- Patton ML, et al. An open, prospective, randomized pilot investigation evaluating pain with the use of a soft silicone wound contact layer vs bridal veil and staples on split thickness skin grafts as a primary dressing. J Burn Care Res. 2013;34(6):674-681.
- Bredow J, et al. Randomized clinical trial to evaluate the performance of a flexible self-adherent absorbent dressing coated with a soft silicone layer after hip, knee or spinal surgery in comparison to standard wound dressing. Poster presentation at the 5th Congress of WUWHS, Florence, Italy, 25-29 Sep 2016.
- Meaume S, et al. A study to compare a new self-adherent soft silicone dressing with a self-adherent polymer dressing in stage II pressure ulcers. Ostomy Wound Manage. 2003;49(9):44-51.
- Herst P et al. Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients. Radiotherapy and Oncology, 2014.
- Gotschall CS, et al. Prospective, randomized study of the efficacy of Mepitel on children with partial-thickness scalds. J Burn Care and Rehabil. 1998;19(4):279-283.
